Effectiveness of smoking cessation in patients with psychiatric disease

Z. Pinar Önen, E. Sen, B. Eris Gülbay, P. Akin Kabalak, O. Akkoca Yildiz, T. Acican, S. Saryal, G. Karabiyikoglu (Ankara, Turkey)

Source: Annual Congress 2012 - Tobacco comorbidity
Session: Tobacco comorbidity
Session type: Thematic Poster Session
Number: 4078
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Z. Pinar Önen, E. Sen, B. Eris Gülbay, P. Akin Kabalak, O. Akkoca Yildiz, T. Acican, S. Saryal, G. Karabiyikoglu (Ankara, Turkey). Effectiveness of smoking cessation in patients with psychiatric disease. Eur Respir J 2012; 40: Suppl. 56, 4078

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Ciobanu Magdalena - 03.09.2012 08:14
very interesting study- congratulations! I have just one "curiosity": from the patients receiving bupropion and having quitted, how many had deppresion? My feeling is that the unusual high rate for bupropion is explained by the anti-depresive effect of bupropion.
You must Login to comment this presentation.


Related content which might interest you:
Smoking cessation in psychiatric patients
Source: ERS Course 2015
Year: 2015




Effectiveness of a specialised intervention for smoking cessation in hospitalised patients
Source: Annual Congress 2007 - Smoking cessation
Year: 2007


Smoking habit, smoking cessation and relapse rates in patients with comorbid diseases
Source: Annual Congress 2010 - Smoking cessation interventions
Year: 2010

Smoking cessation treatment in smokers with psychiatric problems
Source: Annual Congress 2008 - Towards smoking cessation
Year: 2008


Particularities of smoking cessation in patients with HIV/AIDS
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Smoking cessation in patients with pulmonary disorders
Source: International Congress 2014 – PG14 Smoking cessation in patients with pulmonary disorders
Year: 2014


Smoking cessation in asthma patients
Source: International Congress 2017 – PG14 Smoking cessation in patients with respiratory diseases
Year: 2017

Success of smoking cessation among the smoker relatives of patients with serious smoking-related disorders
Source: Eur Respir J 2002; 20: Suppl. 38, 578s
Year: 2002

Impact of the diagnosis of a respiratory disease in smoking cessation
Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations
Year: 2019

The attitude of patients suffering from COPD towards addiction to smoking and attempts to smoking cessation
Source: International Congress 2014 – Passive smoking, active smoking and COPD
Year: 2014

Smoking cessation guidelines in health and chronic diseases
Source: Annual Congress 2006 - PG20 - Smoking cessation in a respiratory medicine setting
Year: 2006



Smoking cessation strategies in patients with COPD
Source: Eur Respir J 2013; 41: 727-734
Year: 2013



Impacts of pharmacist-led smoking cessation program on patients with chronic diseases in a Thai community hospital
Source: International Congress 2015 – Smoking cessation
Year: 2015


Different types of medical intervention and the smoking cessation rate in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 107s
Year: 2006

Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008


Nicotine addiction and smoking history determine compliance in COPD patients enrolled in pulmonary rehabilitation program
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008

Smoking cessation in patients with tobacco related diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 393s
Year: 2006